AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Mar 27, 2024
35599_dirs_2024-03-27_4a63aed2-75b4-4fad-88a9-ba8e082e4a71.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-03-26
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-26 | Common shares | S | 13975 | $10.9013 | Disposed | 91771 | Direct |
Footnotes
F1: Represents shares sold pursuant to a 10b5-1 plan adopted August 16, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20